As of 2025-09-18, the Relative Valuation of Intercept Pharmaceuticals Inc (ICPT) is (21.77) USD. This relative valuation is based on P/E multiples. With the latest stock price at 19.00 USD, the upside of Intercept Pharmaceuticals Inc based on Relative Valuation is -214.6%.
The range of the Relative Valuation is (20.69) - (22.96) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.0x - 15.6x | 12.8x |
| Forward P/E multiples | 14.0x - 21.5x | 16.8x |
| Fair Price | (20.69) - (22.96) | (21.77) |
| Upside | -208.9% - -220.8% | -214.6% |
| Date | P/E |